Clinical trial
An Open-Label Study of Diazoxide Choline Controlled-Release Tablet in Patients With Prader-Willi Syndrome
NCT04086810 is registered in ClinicalTrials.gov with Soleno Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Study of Diazoxide Choline Controlled-Release Tablet in Patients With Prader-Willi Syndrome
- Lead sponsor
- Soleno Therapeutics, Inc.
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- October 31, 2019
- Completion date
- October 31, 2019
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.